In vitro and in vivo anti-hepatitis B virus activities of the lignan niranthin isolated from Phyllanthus niruri L.

Journal of Ethnopharmacology

Volumn 155, Issue 2, 2014, Pages 1061-1067

  Liu, Sheng ^a   Wei, Wanxing ^a   Shi, Kaichuang ^b   Cao, Xun ^a   Zhou, Min ^a   Liu, Zhiping ^a,c  

^a GUANGXI UNIVERSITY   (China)

^b Guangxi Provincial Center for Disease Control and Prevention   (China)

^c GUANGXI TEACHERS EDUCATION UNIVERSITY   (China)

Author keywords

Anti HBV activity; Niranthin; Phyllanthus niruri L.

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; LAMIVUDINE; LIGNAN; NIRANTHIN; UNCLASSIFIED DRUG; VIRUS DNA; 1,3 DIOXOLANE DERIVATIVE; ANISOLE DERIVATIVE; ANTIVIRUS AGENT;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIVIRAL ACTIVITY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CELL VIABILITY; CHROMATOGRAPHY; CONTROLLED STUDY; CYTOTOXICITY; DRUG ISOLATION; DRUG SCREENING; DRUG STRUCTURE; DUCK HEPATITIS B; DUCK HEPATITIS B VIRUS; DUCKLING; FEMALE; HEPATITIS B VIRUS; HEPG2 CELL LINE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; IN VIVO STUDY; LIVER PROTECTION; MALE; NONHUMAN; PHYLLANTHUS NIRURI; PROTEIN EXPRESSION; VIRUS REPLICATION; ANIMAL; CHEMISTRY; DISEASE MODEL; DRUG EFFECTS; DUCK; HEPADNAVIRIDAE INFECTIONS; HEPATITIS B; HEPATITIS, VIRAL, ANIMAL; IC50; ISOLATION AND PURIFICATION; METABOLISM; PHYLLANTHUS; VIROLOGY;

ANAS; DUCK HEPATITIS B VIRUS; EUPHORBIACEAE; HEPATITIS B VIRUS; PHYLLANTHUS NIRURI;

ANIMALS; ANISOLES; ANTIVIRAL AGENTS; DIOXOLES; DISEASE MODELS, ANIMAL; DUCKS; FEMALE; HEP G2 CELLS; HEPADNAVIRIDAE INFECTIONS; HEPATITIS B; HEPATITIS B E ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B VIRUS, DUCK; HEPATITIS, VIRAL, ANIMAL; HUMANS; INHIBITORY CONCENTRATION 50; LIGNANS; MALE; PHYLLANTHUS;

EID: 84906937632     PISSN: 03788741     EISSN: 18727573     Source Type: Journal    
DOI: 10.1016/j.jep.2014.05.064     Document Type: Article

References (26)

1. B.S. Blumberg, I. Millman, P.S. Venkateswaran, and S.P. Thyagarajan Hepatitis B virus and primary hepatocellular carcinoma: treatment of HBV carriers with phyllanthus amarus Vaccine 8 1990 S86 S92
2. D. Chattopadhyay, M.C. Sarkar, T. Chatterjee, R. SharmaDey, P. Bag, S. Chakraborti, and M.T.H. Khan Recent advancements for the evaluation of anti-viral activities of natural products New Biotechnology 25 2009 347 368
3. Z.Y. Chen, A.C. Cheng, M.S. Wang, D.W. Xu, R. Jia, Y.F. Guo, and W. Zeng Viral load in 1-day-old ducklings acutely infected with duck hepatitis B virus by different doses and routes of inoculation Avian Pathology 38 2009 129 134
4. A. Duflot, R. Mehrotra, and S.Z. Yu Spectrum of liver disease and duck hepatitis B virus infection in a large series of Chinese duck with hepatocellular carcinoma Hepatology 21 1995 1483 1491
5. M. Ferrari, M.C. Fornasiero, and A.M. Isetta MTT colorimetric assay for testing macrophage cytotoxic activity in vitro Journal of Immunological Methods 131 1990 165 172
6. N. Gitilin HepatitisB: diagnosis, prevention and treatment Clinical Biochemistry 43 1997 1500 1506
7. C. Guha, S. Mohan, N. Roy-Chowdhury, and J. Roy-Chowdhury Cell culture and animal models of viral hepatitis. Part I: hepatitis B Laboratory Animals (New York) 33 2004 37 46
8. R.L. Huang, Y.L. Huang, J.C. Ou, C.C. Chen, F.L. Hsu, and C. Chang Screening of 25 compounds isolated from Phyllanthus species for anti-human hepatitis B virus in vitro Phytotherapy Research 17 2003 449 453
9. B.E. Korba, F.V. Wells, B. Baldwin, P.J. Cote, B.C. Tennant, H. Popper, and J.L. Gerlin Hepatocellular carcinoma in woodduck hepatitis virus-infected woodchucks: presence of viral DNA in tumor tissue from chronic carriers and animals serologically recovered from acute infections Hepatology 9 1989 461 470
10. C.D. Lee, M. Ott, S.P. Thyagarajan, D.A. Shafritz, R.D. Burk, and S. Gupta Phyllanthus amarus down-regulates hepatitis B virus mRNA transcription and replication European Journal of Clinical Investigation 26 1996 1069 1076
11. H. Li, D. Tian, H. Wu, M. Chen, and A. Chen The effect of Gankang Suppository on duck hepatitis B virus, serum biochemistry and liver histology in ducklings Journal of Huazhong University of Science and Technology-Medical Sciences 28 2008 421 425
12. J.Y. Li, H. Huang, M.Q. Feng, W. Zhou, X.L. Shi, and P. Zhou in vitro and in vivo anti-hepatitis B virus activities of a plant extract from Geranium carolinianum L Antiviral Research 79 2008 114 120
13. J. Ozer, M. Ratner, M. Shaw, W. Bailey, and S. Schomaker The current state of serum biomarkers of hepatotoxicity Toxicology 245 2008 194 205
14. D.M. Parkin, P. Pisani, and J. Ferlay Estimates of the worldwide incidence of 25 major cancer in 1990 International Journal of Cancer 80 1999 827 841
15. R.P. Perrillo Current treatment of chronic hepatitis B: benefits and limitations Seminars in Liver Disease 25 Suppl. 1 2005 S20 S28
16. K.S. Prakash, K.S. Satyan, P. Wahi, and R.P. Singh Comparative hepatoprotective activity of three Phyllanthus species, P. Urinaria, P. Niruri, and P. Simplex, on carbon tetrachloride induced liver injury in the rat Phytotherapia Research 9 1995 594 596
17. S. Pungpapong, W.R. Kim, and J.J. Poterucha Natural history of hepatitis B virus infection: an update for clinicians Mayo Clinic Proceedings 82 2007 967 975
18. K.A. Sims, and A.M. Woodland Entecavir: a new nucleoside analog for the treatment of chronic hepatitis B infection Pharmacotherapy 26 2006 1745 1757
19. J. Torresi, and S. Locarnini Antiviral chemotherapy for the treatment of hepatitis B virus infections Gastroenterology 118 2000 S83 103
20. C.Y. Wang, J.J. Giambrone, and B.F. Smith Detection of duck hepatitis B virus DNA on filter paper by PCR and SYBR green dye-based quantitative PCR Journal of Clinical Microbiology 40 2002 2544 2549
21. W.X. Wei, X.R. Li, K.W. Wang, Z.W. Zheng, and M. Zhou Lignans with anti-hepatitis B virus activities from Phyllanthus niruri L. Phytotherapy Research 26 2012 964 968
22. S.N. Wong, and A.S.F. Lok Update on viral hepatitis: 2005 Current Opinion in Gastroenterology 22 2006 241 247
23. Y.H. Wu, B.J. Hao, H.C. Cao, W. Xu, Y.J. Li, and L.J. Li Anti-hepatitis B virus effect and possible mechanism of action of 3, 4-O-dicaffeoylquinic acid in vitro and in vivo Evidence-based Complementary and Alternative Medicine 2012 2012 1 9
24. M.F. Yuen, and C.L. Lai Treatment of chronic hepatitis B: evolution over two decades Journal of Gastroenterology and Hepatology 26 Suppl 1 2011 S138 S143
25. L.Y. Zheng, L.M. Zang, Q.H. Yang, W.Q. Yu, X.Z. Fang, Y.H. Zhang, X.J. Zhao, N. Wan, Y.T. Zhang, Q.D. Wang, and J.B. Chang Anti-hepatitis B virus activity of a-DDB-DU, a novel nucleoside analogue, in vitro and in vivo European Journal of Pharmacology 702 2013 258 263
26. Z. Zhou, Y. Zhang, X.R. Ding, S.H. Chen, J. Yang, X.J. Wang, G.L. Jia, H.S. Chen, X.C. Bo, and S.Q. Wang Protocatechuic aldehyde inhibits hepatitis B virus replication both in vitro and in vivo Antiviral Research 74 2007 59 64